e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High level of leukotriene B4 in bronchoalveolar lavage fluid is associated with poor prognosis in patients with interstitial pneumonia
T. Izumo, M. Kondo, M. Nagaoka, N. Arai, J. Tamaoki, A. Nagai (Japan)
Source:
Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session:
Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Session type:
E-Communication Session
Number:
5223
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Izumo, M. Kondo, M. Nagaoka, N. Arai, J. Tamaoki, A. Nagai (Japan). High level of leukotriene B4 in bronchoalveolar lavage fluid is associated with poor prognosis in patients with interstitial pneumonia. Eur Respir J 2010; 36: Suppl. 54, 5223
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Lymphocytes in bronchoalveolar lavage fluid might be useful for predicting the prognosis, even in the stable phase of nonspecific interstitial pneumonia
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Year: 2020
Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004
Levels of interferon-γ and interleukin-2 receptor-α for bronchoalveolar lavage fluid were correlated with clinical grade and treatment course of pulmonary tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 466s
Year: 2001
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Elevated NT-3 levels in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 586s
Year: 2007
Changes of pneumonia patients bronchoalveolar lavage fluid cellular components
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
The decrease of surfactant protein D in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Cytokine profiles in bronchoalveolar lavage fluid in patients with pneumocystis pneumonia
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Activity of neutrophils in bronchoalveolar lavage fluid in children with chronic bronchiolitis and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001
Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Elastase and α1-proteinase inhibitor in bronchoalveolar lavage fluid of children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept